LILLY S.A.

Fabricación de otros productos químicos n.c.o.p.


sin logotipo

Alcobendas - Area Metropolitana (Madrid - Comunidad de Madrid)

LILLY S.A.

Fabricación de otros productos químicos

Productos y servicios

Fabricación de productos farmaceúticos


Actividades
Fabricación de otros productos químicos n.c.o.p.
Fabricación de especialidades farmacéuticas
Fabricación de otros productos químicos ncop
Fabricación de productos farmacéuticos de base
Manufacture of other chemical products n.e.c.
Manufacture of pharmaceutical preparations
The company is a business enterprise involved in the research, development and manufacture of pharmaceutical products. It was established in 1963 and is based in Alcobendas, a city located in the Community of Madrid (Spain). The company specializes in a wide range of therapeutic areas, which include neurosciences, feminine health, erectile dysfunction, oncology, diabetes, nervous disorders, clinical depression and infectious diseases. The company's 28,000 square-meter facility in Alcobendas produces approximately 900 million doses every year (in liquid form, capsules and tablets), corresponding to approximately 24 million packages. The company's product offerings include Zyprexa, Prozac, Actos, Humulina, Humalog, ReoPro, Xigris, Gemzar, Alimta, Evista, Forsteo, Cialis and Humatrope. Prozac is a leading anti-depressant brand in the market and has given rise to a number of comparably-functioning therapies for the treatment of clinical depression and other central nervous system disorders such as obsessive compulsive disorder, bulimia nervosa, and panic disorders. Cialis (tadalafil) is a products launched as a competitor to Pfizer's Viagra for erectile dysfunction. Gemzar is used for treating pancreatic cancer, while Humalog is a medicine used to combat diabetes. The company is a subsidiary of Eli Lilly and Company, a global pharmaceutical group and one of the world's largest corporations. Based in Indiana, USA, Eli Lilly and Company employs approximately 42,000 people worldwide and market its medicines in 143 countries. The company has major research and development facilities in nine countries and conducts clinical trials in more than 60 countries.
Datos de contacto
Dirección postal

AVENIDA DE LA INDUSTRIA, 30

CP: 15297 - ALCOBENDAS (Madrid)


Tlf: +34 916635000
Fax: +34 916635131

Web: www.lilly.es
Mail:


NIF: